FDA Approves Expanded Access Program For Lipella Pharma's LP-310 In Oral Lichen Planus ...
Lipella Pharmaceuticals Inc. (LIPO), a clinical-stage biotechnology company, Wednesday said that the U.S. Food and Drug ...